Literature DB >> 34364726

Tobacco Treatment Guideline Use and Predictors Among U.S. Physicians by Specialty.

Daniel A Schaer1, Binu Singh2, Michael B Steinberg3, Cristine D Delnevo2.   

Abstract

INTRODUCTION: Physicians play a critical role in tobacco treatment, being a frequent link to smokers and a trusted source of information. Unfortunately, barriers exist that limit physicians' implementation of evidence-based interventions. This study examines the implementation and predictors of the Ask, Advise, Assess, Assist, Arrange model of tobacco treatment clinical guidelines among U.S. physicians.
METHODS: A national sample of 1,058 U.S. physicians from 6 specialties (family medicine, internal medicine, obstetrics and gynecology, cardiology, pulmonology, and oncology) were surveyed in 2018 (51.8% response rate). Survey domains included demographics, awareness of the guidelines, tobacco treatment practices (i.e., Ask, Advise, Assess, Assist, Arrange model), perceived barriers to treatment, and perceived efficacy of various treatments. Multiple logistic regression analyzed the predictors of implementing guideline activities.
RESULTS: Mean age was 51.3 years, with the majority male (64.4%) and non-Hispanic White (63.9%). Nearly all physicians reported asking patients whether they smoke (95.6%) and advising them to stop (94.8%), slightly fewer assessed the readiness to quit (86.5%), and only a minority assisted with a quit plan (27.4%) or arranged a follow-up (18.6%). Only 18% reported using the U.S. Public Health Service Guidelines in clinical practice. Time-related factors were the most common barriers (53.4%), with patient factors (36.9%) and financial/resource factors (35.1%) cited less frequently. The predictors of implementing aspects of the Ask, Advise, Assess, Assist, Arrange model included physician awareness and utilization of the U.S. Public Health Service Guidelines, specialty, and to a smaller degree, graduating before 1990, not reporting time as a barrier, patient barriers, sex, and higher perceived effectiveness of pharmacotherapy.
CONCLUSIONS: This national survey highlights the need for increased implementation of all aspects of the latest guidelines for evidence-based tobacco treatments, including community-based resources.
Copyright © 2021 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 34364726     DOI: 10.1016/j.amepre.2021.05.014

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  3 in total

1.  A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the "Break Free" program.

Authors:  Joanne G Patterson; Tia N Borger; Jessica L Burris; Mark Conaway; Robert Klesges; Amie Ashcraft; Lindsay Hauser; Connie Clark; Lauren Wright; Sarah Cooper; Merry C Smith; Mark Dignan; Stephenie Kennedy-Rea; Electra D Paskett; Roger Anderson; Amy K Ferketich
Journal:  Addict Sci Clin Pract       Date:  2022-02-14

2.  Effectiveness of Health-Related Behavior Interventions on Physical Activity-Related Injuries in Junior Middle School Students.

Authors:  Dongchun Tang; Weicong Cai; Wenda Yang; Shangmin Chen; Liping Li
Journal:  Int J Environ Res Public Health       Date:  2022-03-29       Impact factor: 3.390

3.  Perceptions and preparedness toward tobacco cessation counseling amongst clinical medical students in Chongqing, Southwest China: A cross-sectional study.

Authors:  Chuang Yang; Wenjin He; Ruihang Deng; Mohan Giri; Haiyun Dai
Journal:  Front Public Health       Date:  2022-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.